UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

被引：0

作者：

Lassman, Andrew ^{[1
]}

Alexander, Brian ^{[2
]}

Berry, Donald ^{[3
]}

Berry, Nicholas ^{[3
]}

Buxton, Meredith ^{[4
]}

Colman, Howard ^{[5
]}

Gan, Hui ^{[6
]}

de Groot, John ^{[7
]}

de la Fuente, Macarena ^{[8
]}

Drappatz, Jan ^{[9
]}

Ducray, Francois ^{[10
]}

Ellingson, Benjamin ^{[11
]}

Gordon, Gary ^{[4
]}

Hyddmark, Emma ^{[4
]}

Johnson, Adam ^{[4
]}

Khasraw, Mustafa ^{[12
]}

Lee, Eudocia ^{[13
]}

Lim, Michael ^{[14
]}

Mcglothlin, Anna ^{[3
]}

Mellinghoff, Ingo ^{[15
]}

Mikkelsen, Tom ^{[16
]}

Nghiemphu, Phioanh ^{[11
]}

Perry, James ^{[17
]}

Powell, Ashley ^{[4
]}

Sulman, Erik ^{[18
]}

Tanner, Krik ^{[19
]}

Untch, Sarah ^{[4
]}

Weller, Michael ^{[20
,21
]}

Wen, Patrick ^{[13
]}

Wick, Antje ^{[22
]}

Yung, Alfred ^{[23
]}

Cloughesy, Timothy ^{[11
]}

机构：

[1] Columbia Univ, New York Presbyterian Hosp, Herbert Irving Comprehens Canc Ctr, Vagelos Coll Phys & Surg, New York, NY USA

[2] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[3] Berry Consultants LLC, Austin, TX USA

[4] Global Coalit Adapt Res, Larkspur, CA USA

[5] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[6] Austin Hlth, Melbourne, Australia

[7] UCSF, San Francisco, CA USA

[8] Univ Miami, Miller Sch Med, Miami, FL USA

[9] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[10] CHU Lyon, Lyon, France

[11] UCLA, Los Angeles, CA USA

[12] Duke Univ, Med Ctr, Durham, NC USA

[13] Dana Farber Canc Inst, Boston, MA USA

[14] Stanford Univ, Stanford, CA USA

[15] Mem Sloan Kettering, New York, NY USA

[16] Henry Ford, Detroit, MI USA

[17] Univ Toronto, Toronto, ON, Canada

[18] NYU, Grossman Sch Med, New York, NY USA

[19] Natl Brain Tumor Soc, Newton, MA USA

[20] Univ Hosp, Zurich, Switzerland

[21] Univ Zurich, Zurich, Switzerland

[22] Heidelberg Univ Hosp, Heidelberg, Germany

[23] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

来源：

NEURO-ONCOLOGY | 2024年 / 26卷

关键词：

D O I：

10.1093/neuonc/noae165.0406

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NOAE165.04

引用

页数：2

共 50 条

[21] RTOG 0525: Molecular correlates from randomized phase III trial of newly diagnosed glioblastoma (GBM).
Aldape, K. D.
Wang, M.
Sulman, E. P.
Cahill, D. P.
Hegi, M.
Colman, H.
Jones, G.
Chakravarti, A.
Mehta, M. P.
Andrews, D. W.
Long, L.
Diefes, K.
Heathcock, L.
Jenkins, R.
Schultz, C. J.
Gilbert, M. R.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[22] Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial
Roth, Patrick
Gorlia, Thierry
Reijneveld, Jaap C.
de Vos, Filip
Idbaih, Ahmed
Frenel, Jean-Sebastien
Le Rhun, Emilie
Sepulveda, Juan Manuel
Perry, James
Masucci, G. Laura
Freres, Pierre
Hirte, Hal
Seidel, Clemens
Walenkamp, Annemiek
Lukacova, Slavka
Meijnders, Paul
Blais, Andre
Ducray, Francois
Verschaeve, Vincent
Nicholas, Garth
Balana, Carmen
Bota, Daniela A.
Preusser, Matthias
Nuyens, Sarah
Dhermain, Frederic
van den Bent, Martin
O'Callaghan, Chris J.
Vanlancker, Maureen
Mason, Warren
Weller, Michael
NEURO-ONCOLOGY, 2024, 26 (09) : 1670 - 1682
[23] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Saran, Frank
James, Allan
McBain, Catherine
Jefferies, Sarah
Harris, Fiona
Cseh, Agnieszka
Pemberton, Karine
Schaible, Jennifer
Bender, Shaun
Brada, Michael
NEURO-ONCOLOGY, 2018, 20 : 20 - 20
[24] A phase 0/2 trigger trial of niraparib in patients with newly diagnosed glioblastoma
Mehta, Shwetal
Sanai, Nader
Margaryan, Tigran
Molloy, Jennifer
Zhang, Hualin
Knight, William
Harmon, Jocelyn
Hong, Amy
Wanebo, John
Braun, Kelly
Kennedy, William R.
Garcia, Michael A.
Barani, Igor J.
Yoo, Wonsuk
Tien, An-Chi
Tovmasyan, Artak
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[25] Phase 2 trial of bavituximab with chemoradiation and adjuvant temozolomide in newly diagnosed glioblastoma
Ly, Ina
Richardson, Leland
Liu, Mofei
Muzikansky, Alona
Lou, Kevin
Reardon, David A.
Arrillaga-Romany, Isabel
Forst, Deborah Anne
Jordan, Justin T.
Lee, Eudocia Quant
Dietrich, Jorg
Nayak, Lakshmi
Wen, Patrick Y.
Chukwueke, Ugonma Nnenna
Giobbie-Hurder, Anita
Choi, Bryan D.
Batchelor, Tracy
Kalpathy-Cramer, Jayashree
Curry, William T.
Gerstner, Elizabeth R.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[26] PAMIPARIB IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA (GBM); PHASE 1B/2 STUDY UPDATE
Piotrowski, Anna
Puduvalli, Vinay
Wen, Patrick
Campian, Jian
Colman, Howard
Pearlman, Michael
Butowski, Nicholas
Battiste, James
Glass, Jon
Cloughesy, Timothy
Schiff, David
van den Bent, Martin
Walbert, Tobias
Ahluwalia, Manmeet
Badruddoja, Michael
Kalra, Amandeep
Aregawi, Dawit
Weller, Michael
Ramakrishnan, Vanitha
Zhang, Kathy
Wood, Katie
Mellinghoff, Ingo
Shih, Kent
NEURO-ONCOLOGY, 2019, 21 : 21 - 22
[27] Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)
Grossman, S. A.
Ye, X.
Chamberlain, M. C.
Mikkelsen, T.
Batchelor, T. T.
Desideri, S.
Piantadosi, S.
Fine, H. A.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[28] A phase 0/2 'trigger' trial of pamiparib or olaparib plus radiotherapy in patients with newly-diagnosed or recurrent glioblastoma
Sanai, Nader
Chang, Yu-Wei
Jiang, Jun
Molloy, Jennifer
Pennington-Krygier, Chelsea
Harmon, Jocelyn
Hong, Amy
Wanebo, John
Kennedy, William
Garcia, Michael
Barani, Igor
Yoo, Wonsuk
Tovmasyan, Artak
Tien, An-Chi
Li, Jing
Mehta, Shwetal
CANCER RESEARCH, 2024, 84 (07)
[29] CC-115 IN NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA IN THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT): A PHASE II RANDOMIZED BAYESIAN ADAPTIVE PLATFORM TRIAL
Rahman, Rifaquat
Trippa, Lorenzo
Fell, Geoffrey
Lee, Eudocia
Arrillaga-Romany, Isabel
Touat, Mehdi
McCluskey, Christine
Brunno, Jennifer
Gaffey, Sarah
Drappatz, Jan
Lassman, Andrew
Galanis, Evanthia
Ahluwalia, Manmeet
Colman, Howard
Nabors, Louis
Hepel, Jaroslaw
Elinzano, Heinrich
Schiff, David
Chukwueke, Ugonma
Beroukhim, Rameen
Nayak, Lakshmi
Mcfaline-Figueroa, Jose
Batchelor, Tracy
Rinne, Mikael
Kaley, Thomas
Lu-Emerson, Christine
Bi, Wenya Linda
Arnaout, Omar
Haas-Kogan, Daphne
Tanguturi, Shyam
Cagney, Daniel
Aizer, Ayal A.
Welch, Mary
Doherty, Lisa
Lavallee, Maria
Fisher-Longden, Brittany
Dowling, Shanna
Geduldig, Jack
Watkinson, Fiona
Santagata, Sandro
Meredith, David
Chiocca, E. Antonio
Reardon, David
Ligon, Keith
Alexander, Brian
Wen, Patrick
NEURO-ONCOLOGY, 2020, 22 : 43 - 44
[30] PAMIPARIB IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED (ND) OR RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA (GBM); PHASE 1B/2 STUDY UPDATE
Piotrowski, Anna
Puduvalli, Vinay
Wen, Patrick
Colman, Howard
Campian, Jian
Pearlman, Michael
Butowski, Nicholas
Cloughesy, Timothy
Battiste, James
Glass, Jon
Schiff, David
van den Bent, Martin
Walbert, Tobias
Ahluwalia, Manmeet
Badruddoja, Michael
Kalra, Amandeep
Pelham, Robert
Zhang, Kathy
Wood, Katie
Weller, Michael
Shih, Kent
NEURO-ONCOLOGY, 2020, 22 : 51 - 51

← 1 2 3 4 5 →